Manager × security

BVF INC/IL GPCR holdings history

Who else holds this security? →

STRUCTURE THERAPEUTICS INC · CUSIP 86366E106 · CIK 1056807

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Log in to see them.
Citable facts

As of Sep 30, 2026, BVF INC/IL reported 2.69M GPCR (shares), valued at $84.16M, or 2.77% of its reported non-derivative portfolio. Filed Nov 16, 2026.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
2.77%
Shares
2.69M
2,691,426
Reported value
$84.16M
USD

Shares decreased 20.06%; reported value decreased 53.42%, and weight changed -1.85 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q3 20262.77%2,691,426SEC filing ↗Filed Nov 16, 2026
Q2 20264.62%3,366,823SEC filing ↗Filed Aug 14, 2026
Q1 20265.31%3,459,358SEC filing ↗Filed May 15, 2026
Q4 20258.15%3,479,022SEC filing ↗Filed Feb 17, 2026
Q3 20253.64%3,203,917SEC filing ↗Filed Nov 14, 2025
Q2 20251.31%1,771,417SEC filing ↗Filed Aug 14, 2025
Q1 20251.25%1,771,417SEC filing ↗Filed May 15, 2025
Q4 20241.63%1,771,417SEC filing ↗Filed Feb 14, 2025
Q3 20242.87%2,238,986SEC filing ↗Filed Nov 14, 2024
Q2 20242.74%2,487,762SEC filing ↗Filed Aug 14, 2024
Q1 20240.96%812,988SEC filing ↗Filed May 15, 2024
Q4 20230.83%812,988SEC filing ↗Filed Feb 14, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20230.83%812,988$33.14MThe prior quarter is outside the free window. Log in for the comparison.SEC filing ↗
Filed Feb 14, 2024
Q1 20240.96%812,988$34.84MShares unchanged; reported value increased 5.15%, and weight changed +0.13 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2024
Q2 20242.74%2,487,762$97.69MShares increased 206.00%; reported value increased 180.37%, and weight changed +1.78 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 20242.87%2,238,986$98.27MShares decreased 10.00%; reported value increased 0.59%, and weight changed +0.13 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 20241.63%1,771,417$48.04MShares decreased 20.88%; reported value decreased 51.11%, and weight changed -1.24 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 20251.25%1,771,417$30.66MShares unchanged; reported value decreased 36.17%, and weight changed -0.38 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2025
Q2 20251.31%1,771,417$36.74MShares unchanged; reported value increased 19.82%, and weight changed +0.06 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 20253.64%3,203,917$89.71MShares increased 80.87%; reported value increased 144.18%, and weight changed +2.33 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2025
Q4 20258.15%3,479,022$241.97MShares increased 8.59%; reported value increased 169.72%, and weight changed +4.51 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 17, 2026
Q1 20265.31%3,459,358$166.74MShares decreased 0.57%; reported value decreased 31.09%, and weight changed -2.84 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2026
Q2 20264.62%3,366,823$180.70MShares decreased 2.67%; reported value increased 8.37%, and weight changed -0.69 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2026
Q3 20262.77%2,691,426$84.16MShares decreased 20.06%; reported value decreased 53.42%, and weight changed -1.85 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 16, 2026
BVF INC/IL · STRUCTURE THERAPEUTICS INC

Take these holdings further.

This page includes 12 of 12 reported holdings. Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_institutional_holdings
{"action":"portfolio","cik":"1056807","quarter":"2026Q3","cusip":"86366E106"}

akkru_institutional_holdings
{"action":"history","cik":"1056807","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP / CLI documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.